Tocilizumab provides dual benefits in treating immune checkpoint inhibitor-associated arthritis and preventing relapse during ICI rechallenge: the TAPIR study

Details

Serval ID
serval:BIB_34BED0C92D50
Type
Autre: use this type when nothing else fits.
Collection
Publications
Institution
Title
Tocilizumab provides dual benefits in treating immune checkpoint inhibitor-associated arthritis and preventing relapse during ICI rechallenge: the TAPIR study
Author(s)
Petit Pierre-Florent (co-first), Daoudlarian Douglas (co-first), Latifyan Sofiya, Bouchaab Hasna, Mederos Nuria, Doms Jacqueline, Abdelhamid Karim, Ferahta Nabila, Mencarelli Lucrezia, Joo Victor, Bartolini Robin, Stravodimou Athina, Shabafrouz Keyvan, Pantaleo Giuseppe, Peters Solange, Obeid Michel
Create date
19/07/2024 8:44
Last modification date
20/07/2024 6:06
Usage data